We Can Medicines Co (ROCO:6929) EV-to-FCF : 26.78 (As of Jan. 19, 2025)

We Can Medicines Co EV-to-FCF Chart

We Can Medicines Co Quarterly Data
	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EV-to-FCF	Get a 7-Day Free Trial								443.07	119.38	33.87	76.98	30.76

Competitive Comparison of We Can Medicines Co's EV-to-FCF

For the Packaged Foods subindustry, We Can Medicines Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

We Can Medicines Co's EV-to-FCF Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, We Can Medicines Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where We Can Medicines Co's EV-to-FCF falls into.

We Can Medicines Co EV-to-FCF Calculation

We Can Medicines Co's EV-to-FCF for today is calculated as:

We Can Medicines Co's current Enterprise Value is NT$2,692 Mil.
We Can Medicines Co's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$101 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

We Can Medicines Co  (ROCO:6929) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

We Can Medicines Co's PE Ratio (TTM) for today is calculated as:

We Can Medicines Co's share price for today is NT$37.25.
We Can Medicines Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-0.150.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

We Can Medicines Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of We Can Medicines Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.

We Can Medicines Co Business Description